Benzodiazepine inhibitors of the MMPs and TACE. Part 2

Bioorg Med Chem Lett. 2004 Aug 16;14(16):4147-51. doi: 10.1016/j.bmcl.2004.06.031.

Abstract

A series of benzodiazepine MMP/TACE inhibitors bearing polar moieties has been synthesized in an effort to optimize inhibitory activity against LPS-stimulated TNF production in human monocytes and oral activity in a murine LPS model.

MeSH terms

  • ADAM Proteins
  • ADAM17 Protein
  • Animals
  • Benzodiazepines / pharmacology*
  • Cell Line
  • Enzyme Inhibitors / pharmacokinetics
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Lipopolysaccharides / pharmacology
  • Matrix Metalloproteinase Inhibitors*
  • Metalloendopeptidases / antagonists & inhibitors*
  • Mice
  • Mice, Inbred BALB C
  • Monocytes / drug effects
  • Monocytes / metabolism
  • Mouth / drug effects
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Enzyme Inhibitors
  • Lipopolysaccharides
  • Matrix Metalloproteinase Inhibitors
  • Tumor Necrosis Factor-alpha
  • Benzodiazepines
  • ADAM Proteins
  • Metalloendopeptidases
  • ADAM17 Protein
  • ADAM17 protein, human
  • Adam17 protein, mouse